Generating medical fluids for kidney replacement therapy

By setting up multiple scales and pumps in the dialysis machine and adjusting the pumping speed using sensors, the online generation of medical fluids in renal replacement therapy is achieved, and the environmental and work burden problems brought by prefilled bags are solved, and the treatment efficiency is improved. Security.

CN118922216APending Publication Date: 2024-11-08GAMBRO LUNDIA AB
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380027941.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-03-16
Filing Date
2023-01-24
Publication Date
2024-11-08

Smart Images

  • Figure CN118922216A_ABST
    Figure CN118922216A_ABST
Patent Text Reader

Abstract

A system for generating a medical fluid for renal replacement therapy is operated by a control device according to a method. In the method, a first pump (P1) is operated to convey a first fluid (F1) from a first container (3a) arranged on a first scale (2a) into a supply path (4a), and a second pump (P2) is operated to convey a second fluid (F2) from a second container (3b) arranged on a second scale (2b) into the supply path (4a) to generate a mixture therein. The speed of at least one of the pumps (P1, P2) is adjusted until the sensor (22) measures a target value of the composition-related parameter. When the sensor (22) measures a target value, a relationship between a change in weight of the first and second scales (2a, 2b) is determined. Subsequently, on the basis of the signals (S1, S2) from the scales (2a, 2b), the medical fluid is generated in the supply path (4a) by operating the pumps (P1, P2) to achieve the relationship. The supply path (4a) may be disposable, and the sensor (22) may be reusable and arranged in the bypass path (20).
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present disclosure relates to the field of renal replacement therapy and, in particular, to the generation of medical fluids for use in such therapy. Background Art

[0002] Renal replacement therapy (RRT) is a therapy that replaces the normal blood filtering function of the kidneys. This therapy is used when the kidneys are not functioning well (this is called renal failure and includes acute kidney injury (AKI) and chronic kidney disease (CKD)). RRT involves removing water from the blood of patients with renal failure, as well as the exchange of solutes with the blood. An example of RRT is extracorporeal blood therapy, in which the blood circulates outside the patient's body and is connected to one or more medical fluid interfaces. Modes of extracorporeal blood therapy include hemodialysis (HD), hemofiltration (HF) and hemodiafiltration (HDF). Another example of RRT is peritoneal dialysis (PD), in which a medical fluid is infused into the patient's peritoneal cavity to contact the patient's blood through the peritoneum.

[0003] The medical fluid used in HD and PD is generally called dialysis fluid. In HF, the medical fluid is called replacement fluid, since it is infused into the patient's blood to replace the fluid removed during treatment. In HDF, both dialysis fluid and replacement fluid are used.

[0004] By using different types of dialysis machines, extracorporeal blood therapy of HD, HF or HDF treats AKI patients in different ways compared to CKD patients. Typically, AKI patients are treated continuously over a longer period of time and at a lower fluid flow rate compared to CKD patients. This continuous treatment is commonly referred to as CRRT (continuous renal replacement therapy). In order to ensure accurate and consistent monitoring and control of fluid removal, called ultrafiltration, AKI machines are usually provided with scales, which are used to measure the weight of fresh treatment fluid and the weight of used treatment fluid during treatment. CKD machines instead use flow meters or positive displacement pumps to control ultrafiltration.

[0005] A PD machine, also called a cycler, may include at least one scale to measure the weight of fresh treatment fluid infused into the peritoneal cavity and the weight of spent treatment fluid withdrawn from the peritoneal cavity.

[0006] RRT consumes large amounts of medical fluids over time. In some modes of RRT, pre-made medical fluids are delivered to the point of care in pre-filled bags. For example, conventional PD is performed using pre-filled bags. AKI machines are configured to use pre-filled bags of medical fluids by staff arranging the pre-filled bags on a scale prior to treatment and replacing the pre-filled bags as needed. CKD machines, on the other hand, have an integrated capability to generate medical fluids on demand by mixing one or more concentrates with water, so-called online fluid generation. Recently, PD machines with integrated online fluid generation capabilities have been proposed.

[0007] The use of large quantities of medical fluids has a significant environmental impact due to transportation and the consumption of large amounts of plastic materials to produce the pre-filled bags. In intensive care units, the management and handling of pre-filled bags at the point of care can be a burden on staff, taking up time and diverting staff attention from other tasks. Therefore, it is generally desirable to also be able to generate medical fluids online in AKI machines, and preferably without the need to replace existing AKI machines. Summary of the invention

[0008] One object is to at least partially overcome one or more limitations of the prior art.

[0009] Another object is to enable online generation of medical fluids by a dialysis machine comprising multiple scales.

[0010] One or more of these objects, as well as additional objects that may emerge from the following description, are achieved at least in part by a method for generating a medical fluid for renal replacement therapy, a control device, a computer-readable medium, a system for generating a medical fluid, and a disposable device, embodiments of which are defined by the dependent claims.

[0011] The first aspect is a computer-implemented method for generating a medical fluid for renal replacement therapy. The method includes: operating a first pump to deliver a first fluid from a first container arranged on a first scale to a supply path, the supply path extending to an outlet of the medical fluid; operating a second pump to deliver a second fluid from a second container arranged on a second scale to the supply path to generate a mixture of the first fluid and the second fluid in the supply path; measuring a component-related parameter of the mixture by a sensor; and adjusting the pumping speed of at least one of the first pump and the second pump until the sensor measures a target value of the component-related parameter. The method also includes: when the sensor measures the target value, determining a relationship between a first weight change of the first scale and a second weight change of the second scale based on a first output signal and a second output signal from the first scale and the second scale; and generating the medical fluid in the supply path. The generating step includes: operating the first pump and the second pump based on the first output signal and the second output signal to achieve a relationship between the first weight change and the second weight change.

[0012] The second aspect is a control device. The control device includes a circuit configured to perform the method of the first aspect, and a signal interface configured to output control signals for a first pump and a second pump. The signal interface is further configured to receive a first output signal and a second output signal from a first scale and a second scale and a sensor signal representing a component-related parameter from a sensor.

[0013] A third aspect is a computer readable medium comprising computer instructions which, when executed by a processor, cause the processor to perform the method of the first aspect.

[0014] The fourth aspect is a system for generating a medical fluid for renal replacement therapy. The system includes a first scale, a first container arranged on the first scale, a second scale, and a second container arranged on the second scale. The system also includes: a supply path, which is configured to receive a first fluid from the first container and a second fluid from the second container, and extends to an outlet of the medical fluid; a first pump, which is arranged to deliver the first fluid from the first container to the supply path; a second pump, which is arranged to deliver the second fluid from the second container to the supply path to generate a mixture of the first fluid and the second fluid in the supply path; a sensor, which is configured to measure a component-related parameter; and a control device as described in the second aspect.

[0015] The fifth aspect is a disposable device used in the system of the fourth aspect. The disposable device includes: a first container, a supply path, and a connecting pipeline, the connecting pipeline is in fluid communication with the supply path and extends to a first terminal fluid connector, the first terminal fluid connector is configured to be connected to a second container. The disposable device also includes a bypass path, the bypass path extends from the supply path to a second terminal fluid connector, the second terminal fluid connector is configured to be connected to an inlet connector in fluid communication with the sensor.

[0016] Other objects and aspects, as well as embodiments, features and technical advantages will become apparent from the following detailed description, the appended claims and the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] Figure 1 is a schematic diagram of an example system for dialysis treatment.

[0018] Figure 2A-2B They are used for Figure 1 Schematic diagram of the disposable devices and machine components in the system.

[0019] Figure 3A-3B The results for the ongoing treatment and the intermediate update phase are shown in Figure 2. Figure 1 system.

[0020] Figure 4 is Figure 1 A flow chart of an example method for performing fluid control in a system.

[0021] Figure 5A-5B They are shown in Figure 4 During the first preparation stage and the second preparation stage in the method Figure 1 system.

[0022] Figure 6-7 Depicted Figure 1 Variations of the system in .

[0023] Figure 8 Yes Operation Figure 1 A flowchart of an example method of a system.

[0024] Fig. 9 is a schematic diagram of an example water supply including a reusable sensor.

[0025] Figures 10A-10B is a side view of a reusable sensor before and after manipulation of a disposable line set to load fluid into the sensor.

[0026] Fig.11 is a flow chart of an example procedure for performing fluid control during a dialysis treatment interruption.

[0027] Fig.12 is a schematic diagram of an example system for generating medical fluids.

[0028] Figures 13A-13B is a flowchart of an example program using the auxiliary sensor. DETAILED DESCRIPTION

[0029] Embodiments will now be described more fully hereinafter with reference to the accompanying drawings, in which some, but not all, embodiments of the invention are shown. Indeed, the invention may be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure may satisfy applicable legal requirements. Like numbers refer to like elements throughout.

[0030] Moreover, it should be understood that any advantages, features, functions, devices and / or operational aspects of any embodiment of the present invention described and / or contemplated herein may be included in any other embodiment of the present invention described and / or contemplated herein, and / or vice versa, where possible. In addition, unless otherwise expressly stated, any term expressed in the singular herein is also intended to include the plural form, where possible, and / or vice versa. As used herein, "at least one" should mean "one or more", and these phrases are intended to be interchangeable. Therefore, the terms "one" and / or "an" should mean "at least one" or "one or more", although the phrases "one or more" or "at least one" are also used herein. As used herein, unless the context requires otherwise due to the language of expression or necessary implication, the word "including" or variations such as "comprises" or "comprising" are used in an inclusive sense, that is, specifying the presence of the described features, but not excluding the presence or addition of other features in various embodiments.

[0031] In addition, it should be understood that although the terms first, second, etc. can be used to describe various elements in this article, these elements should not be limited by these terms. These terms are only used to distinguish one element from another element. For example, the first element can be called the second element, and similarly, the second element can be called the first element without departing from the scope of this disclosure. As used herein, the terms "multiple", "plural" and "plurality" are intended to indicate that two or more elements are provided. The term "and / or" includes any and all combinations of one or more associated listed elements.

[0032] For brevity and / or clarity, well-known functions or structures may not be described in detail. Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the present disclosure belongs.

[0033] The present disclosure relates to techniques for online generation of medical fluids used in renal replacement therapy (RRT). As used herein, RRT refers to any treatment that replaces or supplements the normal blood filtering function of the kidneys in a patient. RRT can involve removing water from the patient's blood, and exchanging solutes with the blood. The techniques for online fluid generation will be exemplified below with reference to hemodialysis (HD), although it can be applied to any mode of extracorporeal blood therapy or peritoneal dialysis (PD).

[0034] As used herein, online fluid generation refers to the generation of medical fluids on the fly by mixing various components in appropriate proportions. Online fluid generation can include on-demand fluid generation, where the rate of production of the medical fluid is adjusted to match the rate of consumption of the medical fluid, for example, by ongoing RRT. It is also conceivable that online fluid generation independent of the rate of consumption of the medical fluid can be achieved, for example, by providing the generated medical fluid to a storage vessel or reservoir.

[0035] A medical fluid may be any fluid that is consumed as part of RRT and is also referred to as a "treatment fluid". In the context of extracorporeal blood therapy, the medical fluid may be a dialysis fluid that interfaces with the blood in a filtration unit commonly referred to as a "dialyser". Alternatively or additionally, the medical fluid may be a so-called replacement fluid or substitution fluid that is infused into the blood upstream or downstream of the dialyzer, for example as part of hemofiltration (HF) or hemodiafiltration (HDF), as is known in the art. In the context of PD, the medical fluid may be a dialysis fluid that is infused into the patient's peritoneal cavity and interfaces with the patient's blood through the peritoneum lining the peritoneal cavity.

[0036] Medical fluids used for RRT have a well-defined composition that is suitable for a specific treatment and patient. In online generation, the composition of the medical fluid may be given by medical guidelines and / or set by a caregiver for a specific patient or group of patients. Medical guidelines may also define the permissible deviations from the nominal concentrations of various solutes in the medical fluid.

[0037] As used herein, a "disposable device" (or component / device / sensor, etc.) is a device that is intended to be used only for a limited time, after which it is replaced by a new disposable device. Depending on the disposable device, the limited time may correspond to a single treatment session or a predetermined number of treatment sessions, or be given by a predetermined maximum time period. In another alternative, the disposable device may be replaced each time a new patient is treated.

[0038] As used herein, a "reusable device" (e.g., a sensor) is a device that has a longer operating life than a disposable corresponding device. In some embodiments, a reusable device is not intended to be replaced at all. Therefore, at least in theory, its operating life is unlimited. Informally, such devices are often referred to as "permanent" or "permanently installed", although if the device is deemed to fail, it will be replaced.

[0039] As used herein, a "treatment session" or "session" refers to a period of time during which a patient is subjected to RRT using a dialysis machine. The period of time begins when the patient is connected to the dialysis machine and ends when the patient is disconnected from the dialysis machine.

[0040] In the technology proposed in this article, a medical fluid is generated as a mixture of two or more component fluids. The component fluids are provided from corresponding containers arranged on corresponding scales. The technology is based on such recognition that it may be advantageous to control the supply of the component fluids based on the measurement signal from the scale. If the mixing ratio of the component fluids is known, such control is possible. Although the mixing ratio can be determined theoretically based on the nominal composition of the component fluids, the use of the theoretical mixing ratio may introduce unacceptable deviations in the composition of the medical fluid, for example, if the actual composition of the component fluids deviates from its nominal composition, or if the wrong component fluid is installed on the scale in the dialysis machine. Therefore, the use of the theoretical mixing ratio may require strict tolerances on the composition of the corresponding component fluids, and may also require the implementation of special measures to prevent human errors when the container is installed on the scale.

[0041] An alternative method is to control the supply of the corresponding component fluid based on the feedback signal generated by the sensor, which is arranged to measure the component-related parameter (CRP) of the medical fluid, such as conductivity. Therefore, this CRP sensor is arranged in the main flow path of the medical fluid upstream of the dialyzer to provide continuous feedback on the current value of CRP when generating the medical fluid. This method is generally used for CKD machines with integrated capabilities for online fluid generation, as discussed in the background technology section. One disadvantage of this method is that, for example, after each treatment course, the CRP sensor needs to be thoroughly disinfected intermittently. Since the CRP sensor is located in the main flow path for the medical fluid, it is necessary to prevent microorganisms from growing in the CRP sensor because such microorganisms may be carried into the medical fluid and potentially harm the patient. In order to avoid the need for disinfection, the CRP sensor can be installed as a disposable unit instead, which is discarded after use, for example, after each treatment course. However, this will significantly increase the cost of processing. For example, conductivity sensors of sufficient accuracy are quite expensive.

[0042] In view of the mixing ratio, if the mixing can be controlled in turn based on the measurement signal from the scale, all these disadvantages can be overcome. The technology proposed in this article derives mixing control data (MCD) by using a CRP sensor in the arrangement described below. MCD describes the actual composition of the component fluids and specifies the desired relationship between the measurement signals from the scale. MCD thus replaces the theoretical mixing ratio and eliminates the associated disadvantages. At the same time, by using a clever tuning program for deriving MCD, the need for intermittent replacement of the CRP sensor is also eliminated. As will be described in further detail below, the tuning program involves guiding a mixture of two component fluids from a corresponding container on a corresponding scale through the CRP sensor while adjusting the supply rate of at least one of the component fluids. When the CRP sensor measures a target value corresponding to the desired mixing ratio between the component fluids, the current relationship between the weight changes of the scale is determined. If included in a medical fluid, the tuning program can be repeated for another component fluid, thereby generating a set of relationships that produce the desired mixing ratio of the component fluids in the medical fluid. When a medical fluid is to be generated and used in an RRT, the supply of the component fluids is controlled to achieve the relationship between the weight changes of the scale, thereby inherently generating a medical fluid with a desired composition. Since the supply of the component fluids is controlled based on the measurement signal from the scale, no continuous feedback from the CRP sensor is required when generating the medical fluid. This means that the CRP sensor can be arranged to be exposed to the component fluid only during the tuning procedure. In other words, the medical fluid for use in the RRT does not need to pass through the CRP sensor and is therefore not exposed to any microorganisms that may be present in the CRP sensor. Thereby, the need for intermittent disinfection of the CRP sensor, as well as the need to intermittently replace the CRP sensor, is alleviated. In addition, by limiting its exposure to medical fluids, fouling of the CRP sensor is reduced, for example in the form of scaling. Therefore, the operating life of the CRP sensor is extended, and even permanently installed CRP sensors can be used. Since CRP sensors are typically expensive, significant cost savings are possible.

[0043] As described in the background section, commercially available dialysis machines for treating acute kidney injury (AKI) typically include scales for controlling dialysis flow parameters. As will be understood from below, such existing dialysis machines can be simply reconfigured to use the technology proposed herein. Therefore, dialysis machines designed to use pre-made bags of medical fluids can be converted to produce medical fluids online. Of course, it is also conceivable to develop new dialysis machines to utilize the technology proposed herein for any mode of extracorporeal blood therapy or PD.

[0044] Now refer to Figure 1Various embodiments are described, which show an example system 1 for dialysis treatment, specifically, a system for extracorporeal blood treatment by hemodialysis. System 1 is configured to generate dialysis fluid on demand for hemodialysis. System 1 includes scales 2a-2d, which are configured to provide corresponding measurement signals S1-S4 representing quality. Containers 3a-3d are arranged on corresponding scales 2a-2d. Containers 3a-3d can be placed to be placed on scales 2a-2d, rather than being suspended on scales 2a-2d as shown. Containers 3a-3d can be rigid or flexible, and can be any material, such as plastic. In the example shown, dialysis fluid is generated by mixing three fluids F1, F2, F3 ("component fluids"). The first fluid F1 in the first container 3a is water, and the second fluid F2 and the third fluid F3 in the second container container 3b and the third container 3c are different liquid concentrates. For example, the concentrate can be so-called A and B concentrates known in the art. In the following, it is assumed that F2 is an A concentrate and F3 is a B concentrate, although the reverse is equally possible. The system 1 also includes a pumping arrangement comprising pumping devices ("pumps") P1-P6. The respective pumps P1-P6 may be of any type. If the fluid paths in the system are defined by disposable devices (below), the pumps P1-P6 are typically peristaltic pumps that engage the outside of a dedicated conduit. The pumps P1-P6 operate in response to control signals C1-C6.

[0045] The first fluid line 4a extends from the first container 3a to the dialyzer 7 and forms the main supply path of the dialysis fluid. The second fluid line 4b extends from the second container 3b to the first connector 6' on the first fluid line 4a, and the third fluid line 4c extends from the third container 3c to the second connector 6' downstream of the first connector 6' on the first fluid line 4a. The system 1 is configured to allow the flow of F2 to meet the flow of F1 in the first fluid line 4a within the connector 6' and downstream of the connector 6' and form a mixture. Similarly, the system 1 is configured to allow the flow of F3 to meet the mixed flow of F1 and F2 in the first fluid line 4a within the connector 6' and downstream of the connector 6' and form a mixture. The mixing of F1 and F2 may or may not be completed at the connector 6", but the mixing of F1, F2 and F3 is completed at the outlet of the first fluid line 4a, that is, at the inlet into the dialyzer 7. In the example shown, pump P1 is arranged in the first fluid circuit 4a to define the flow rate of the dialysis fluid ("main flow"), and pumps P2, P3 are arranged in the second and third fluid circuits to define the flow of F2, F3, respectively. Thus, pumps P2, P3 are operable to control the amount of F2, F3 mixed into F1 in the first fluid circuit 4a.

[0046] Despite Figure 1Not shown, the system 1 may include one or more devices configured to promote mixing, for example within the respective connectors 6', 6". In some embodiments, the respective connectors 6', 6" are 3-way connectors. A non-limiting example of a 3-way connector with a mixing enhancement device is disclosed in patent document WO2009 / 030973, which is incorporated herein by reference. In one variation, the mixing enhancement device may be separate from the connectors 6', 6" and located downstream thereof. Such a separate device may be configured to increase the Reynolds number of the mixture and / or at least one upcoming fluid flow. Alternatively, the separate device may be configured as a conventional static mixer, or a recirculation loop, in which the mixture circulates to promote mixing before being delivered to the dialyzer 7.

[0047] Dialyzer 7 is a conventional blood filter, wherein semi-permeable membrane 7 'is arranged to define a first chamber for dialysis fluid and a second chamber for blood. One end of the first chamber is connected to receive dialysis fluid from the first fluid line 4a. The dialysis fluid flows through the first chamber and leaves the dialyzer 7 at the opposite end. The dialysis fluid leaving the dialyzer 7 is "used". In order to distinguish between fresh dialysis fluid and used dialysate, the latter is represented as "effluent (effluent, waste liquid)" in this article and represented by EF. The second chamber of the dialyzer 7 is arranged to receive blood from the extraction line 8a, which is connected to the object 10 by the connector 9a. Typically, the object 10 is a dialysis patient, and the connector 9a is an access device (catheter, needle, etc.) that is fluidly communicated with the patient's circulatory system. However, it is also conceivable that the object 10 is a reservoir of blood to be processed. The second chamber is also fluidly communicated with the return line 8b extending to the connector 9b, which is connected to the object 10. A pump P5 is arranged along the extraction line 8a to pump blood from the subject or patient 10 through the extraction line 8a, the second chamber and the return line 8b back to the subject 10. While passing through the second chamber, the blood interfaces with the dialysis fluid through the membrane 7' and is thereby processed by hemodialysis. The principles of hemodialysis are well known to those skilled in the art and will not be further explained here. It should be understood that Figure 1 The examples in are simplified and may include additional conventional components such as clamps, pressure sensors, air detectors, etc.

[0048] exist Figure 1In the example of, the first chamber fluid of dialyzer 7 is connected to the effluent line 12, which extends to the fourth container 3d. Pump P4 is arranged along the effluent line 12 to pump EF from the dialyzer 7 to the container 3d. The container 3d is also fluidly connected to the discharge line 14. The discharge line 14 is a part of the discharge path extending to the sewer (drain, drain port) 16. Pump P6 is arranged along the discharge line 14 to pump EF from the container 3d to the sewer 16. Pump P6 is operable to completely or at least partially empty the container 3d during the discharge phase. As will be described below, when the container 3d is considered to be (enough) full, the discharge phase can be selectively started.

[0049] In the example shown, the discharge path includes a discharge line 14 and an adjacent pipe section 20b connected to a sensor 22, and another adjacent pipe section 20c extending from the sensor 22 to the sewer 16. The sensor 22 is configured to measure a composition-related parameter (CRP) passing through the fluid. CRP can represent conductivity, or equivalently represent resistivity. In one variation, CRP represents the concentration of a substance in the fluid, specifically, a substance present in a fresh dialysis fluid, such as bicarbonate or electrolytes such as sodium, potassium, calcium, magnesium, chloride, etc. If the dialysis fluid is generated for PD, the substance can alternatively be an osmotic agent, such as glucose. In another alternative, CRP can represent the concentration of hydrogen ions, for example in the form of a pH value. As shown, the sensor 22 provides a measurement signal S5 indicating the CRP.

[0050] As mentioned above, the first fluid F1 is water, which is the main component in the dialysis fluid. In order to maintain the continuous generation of the dialysis fluid, the container 3a may need to be replenished. To this end, the system 1 includes a water supply device 17, which is configured to generate water of sufficient quality for the dialysis fluid. The supply device 17 is connected to the container 3a by a water supply line 18. The supply device 17 can be operated to supply water to the container 3a according to the control signal C7 to refill the container 3d completely or at least partially during the refilling phase. As will be described below, when the container 3a is considered to be (sufficiently) empty, the refilling phase can be selectively started.

[0051] exist Figure 1In the embodiment, the bypass line 20a is arranged to extend from the first fluid line 4a to the discharge path. The system 1 also includes a valve device, which can be operated in different states. In the first state, the fluid flow is guided to the dialyzer 7 along the first fluid line 4a. In the second state, the fluid flow is prevented from flowing to the dialyzer 7, but turned to the bypass line 20a, and guided from the bypass line 20a to the discharge path towards the sewer 16. Therefore, in the second state, a "bypass path" is defined, which includes the bypass line 20a and the pipeline sections 20b, 20c. In the third state, EF is selectively allowed to flow from the container 3d along the discharge path to the sewer 16, that is, through the discharge line 14 and the pipeline sections 20b, 20c. The valve device cannot be operated in the first state and the second state at the same time (mutually exclusive), nor can it be operated in the second state and the third state. Depending on the embodiment, the valve device can be operated in the first state and the third state at the same time, or it can not be operated in the first state and the third state at the same time. In the example shown, the valve device includes a first valve device 21a and a second valve device 21b, which are arranged at the upstream end and the downstream end of the bypass line 20a, respectively. The corresponding valve devices 21a, 21b can be three-way valves as shown in the figure, or a combination of on / off valves. The state of the valve device is set by control signals C8, C9 for the first valve device 21a and the second valve device 21b. If the fluid path in the system is defined by a disposable device (below), the valve device may include an actuator configured to engage the outside of a dedicated tube to selectively close the fluid channel. Such a valve device may include any type of pinch valve or clamp.

[0052] like Figure 1As shown, the control device 30 is configured to control the operation of any system described herein. If the system 1 is operated by a dialysis machine, the control device 30 can be a controller or a separate controller of the dialysis machine. The control device 30 is configured to receive a measurement signal represented as Sj and output a control signal represented as Ci. As understood, Ci can include C1-C9, and Sj can include S1-S5. The control device 30 can be configured to generate a control signal Ci according to a control program including computer instructions. The control program is also configured to operate based on the measurement signal Sj. The control device 30 includes a circuit including one or more processors 31 and a computer memory 32. The control program is stored in the memory 32 and executed by the processor 31. The control program can be supplied to the control device 30 on a computer readable medium, which can be a tangible (non-temporary) product (e.g., magnetic medium, optical disk, read-only memory, flash memory, etc.) or a propagation signal. In the example shown, the control device 30 includes a signal interface 33a for providing a control signal Ci and receiving a measurement signal Sj. The control device 30 also includes an input interface 33b for connecting to one or more input devices 34, which enables an operator to input control data, and an output interface 33c for connecting to one or more UI devices 35, which is used to provide feedback data to the operator. For example, the input device 34 may include a keyboard, a keypad, a computer mouse, a control button, a touch screen, a printer, a microphone, etc., and the UI device 35 may include a display device, a touch screen, an indicator light, an alarm device, a speaker, etc. The operator may be a clinically experienced person, such as a physician or a nurse, or a patient.

[0053] Figure 1 The system 1 in also includes a plurality of connectors 19a-19f attached to various fluid lines. The provision of connectors 19a-19f enables the system 1 to include disposable components or "disposable devices" that can be connected to corresponding connectors in the system and discarded after use. The disposable components are engaged with machine components to form at least a part of the system. In a dialysis system, the machine components are often referred to as dialysis machines or "monitors." The disposable components can vary depending on the treatment mode to be performed. Figure 2A An example of a disposable component 1a for HD treatment is shown in FIG. The disposable component 1a may be a single component as shown, or a collection of subcomponents that may be connected. The disposable component 1a is provided as a dedicated attachment for mounting on a machine component. Although in Figure 2A Not shown in the figure, but disposable part 1a may also include one or more containers 3b, 3c, which will be filled with liquid concentrate when being transported. As known in the art, dialyzer 7 and blood lines 8a, 8b are also disposable and may or may not be included in disposable part 1a.

[0054] exist Figure 2A In the embodiment of the present invention, disposable component 1a defines a fluid path on the "non-blood side" of the system. Specifically, disposable component 1a includes a water supply line 18, a container 3a, fluid lines 4a, 4b, 4c, connectors 6' and 6", a bypass line 20a, an effluent line 12, a container 3d, a discharge line 14, and a line segment 20b. A connector 19a is arranged at the end of line 18 for connection to a supply device 17, a connector 19b is arranged at the end of line 4b for connection to a container 3b, a connector 19c is arranged at the end of line 4c for connection to a container 3c, and a connector 19d is arranged at the end of line 4a for connection to a bypass line 20b. The disposable component 1a is disposed at the end of the effluent line 12 for connection to the inlet of the second chamber of the dialyzer 7, a connector 19e is arranged on the end of the effluent line 12 for connection to the outlet of the second chamber of the dialyzer 7, and a connector 19f is arranged on the end of the line 20b for connection to the CRP sensor 22. The provision of the connectors 19b, 19c allows the operator to remove the containers 3b, 3c when emptying and reattaching new containers 3b, 3c filled with concentrate F2, F3. The disposable component 1a is discarded after use, for example after completion of a treatment course, after a predetermined maximum usage time, or whenever a new patient is treated.

[0055] In disposable component 1a, the fluid circuit may be defined by a plastic tube. As described above, pumps P1-P6 may be peristaltic pumps that engage the outside of the tube to generate a moving compression of the tube, thereby forcing the fluid to move along the tube. Conventionally, in order to enable the use of a peristaltic pump, the tube is provided with a dedicated engagement portion, also called a pump segment, which is configured to be engaged by a compression element of the peristaltic pump. Figure 2A In the embodiment, the pump sections 5a', 5b', 5c' are configured to be driven by pumps P1, P2, P3 ( Figure 1 ) are joined, and the pump sections 13', 15' are configured to be driven by pumps P4, P6 ( Figure 1 ) join.

[0056] The disposable part 1a can be used with Figure 2B The machine part 1b shown is engaged. In the example shown, the machine part 1b includes pumps P1-P6, which can be used to engage with the pump section of the disposable part 1a. The machine part 1b also includes valve devices 21a, 21b, which can be used to engage with the fluid pipeline in the disposable part 1a. The scales 2a-2d are also included in the machine part 1b and are configured to carry the corresponding containers 3a-3d. The machine part 1b also includes a control device 30, thereby forming an operating device for performing RRT. Figure 2B In the example of FIG. 1 , machine component 1 b also includes a CRP sensor 22 , although alternative placements are possible (described below).

[0057] Figure 3A It is shown that when the control device 30 ( Figure 1 ) when operating the system 1 to perform HD therapy. Figure 3A In the and all other drawings, an open / filled pump symbol indicates a stopped / operating pump, and an open / filled valve symbol indicates a closed / open valve path. Figure 3A In the process, pumps P1-P3 are operated together to pump water (F1) and concentrate (F2, F3) into the supply line 4a in a well-defined ratio, while the valve device is set in its first state to guide the fluid F1-F3 into the first chamber of the dialyzer 7. In this process, water and concentrate are mixed into the dialysis fluid in the line 4a. At the same time, pump P5 is operated to pump blood through the second chamber of the dialyzer 7. Pump P4 is also operated to pump effluent from the dialyzer 7 into the container 3d. By the correct operation of pumps P1-P4, fluid can be extracted from the blood in the dialyzer 7 through the membrane 7'. This extraction of fluid is called ultrafiltration, and the extracted fluid is called ultrafiltrate. The ultrafiltration rate at any given time is given by the flow rate difference between pump P4 and pump P1, that is, given by the difference between the outflow of effluent from the dialyzer 7 and the inflow of dialysis fluid into the dialyzer 7, and the cumulative amount of ultrafiltration rate (UFR) and ultrafiltrate (UF) can both be monitored using signals S1-S4. UFR is equal to the difference between the weight increase per unit time of container 3d and the weight reduction per unit time of container 3a-3c. UF within a certain time period is given by the difference between the weight increase of container 3d and the weight reduction of container 3a-3c during the time period. In some embodiments, control device 30 is configured to control pump P1 and / or pump P4 to achieve the set value of UFR and / or UF based on output signals S1, S4.

[0058] It can be appreciated that the system 1 is operated to generate dialysis fluid online and on demand. Furthermore, the dialysis fluid is generated within the disposable component 1a. This means that by attaching the correctly configured disposable component 1a and by reconfiguring the control device ( Figure 1 30), an existing dialysis machine with a scale can be configured for online generation of dialysis fluid, for example by updating its control program.

[0059] During the dialysis treatment, the liquid level in the containers 3a, 3b and 3c decreases, while the liquid level in the container 3d increases, as shown by the arrows. Eventually, the container 3a will be exhausted, which causes the need to replenish the container 3a by starting the above-mentioned refilling phase. Similarly, the container 3d will eventually be full of effluent (EF), which causes the need to empty the container 3d by starting the above-mentioned discharge phase. The control device 30 can monitor the need for replenishment and discharge based on the weight of the respective container 3a, 3d given by the signal S1, S4. Figure 3BThe system 1 is shown during a refill and drain phase, which in this example are performed simultaneously. During the refill phase, the supply device 17 is operated to supply water, causing the liquid level in the container 3a to increase. During the drain phase, the pump P6 is operated to pump EF from the container 3d into the drain path, and the valve device is set in its third state to direct EF to the sewer 16. In the embodiment shown, during the drain and refill phases, the dialysis treatment is interrupted by stopping the pumps P1-P5. However, the pump P5 can be operated to avoid blockages in the blood line. Figure 3A and Figure 3B In an alternative to the superposition of , the dialysis treatment is continued during the drain phase and / or the refill phase. It can be appreciated that during such a drain phase and refill phase, UFR and UF cannot be reliably monitored or controlled by using the signals S1-S4.

[0060] The liquid concentrates F2, F3 will be consumed at a much lower rate than the water F1. When the control device 30 detects that one of the containers 3b, 3c is empty based on the signals S2, S3, it can be activated at the UI device 35 ( Figure 1 ) to prompt the operator to replace the container. During the replacement, the dialysis treatment is stopped, and the operator manually disconnects the connector 19b / 19c from the empty container 3b / 3c and attaches the full container 3b / 3c. The control device 30 is then operated to resume the dialysis treatment.

[0061] Figure 4 4 is a flow chart of an exemplary method 400 for controlling fluid flow in the system 1. The method 400 may be performed by the control device 30. The method 400 comprises two preparation phases PH1, PH2 which are performed before the dialysis treatment and which aim to derive the above-mentioned "mixing control data" (MCD) by using the CRP sensor 22. Subsequently, the MCD is used by the control device 30 to control the pumps P1-P3 to generate the dialysis fluid during the dialysis treatment. Figure 4 Optional steps are indicated by dashed lines. Although some of these optional steps are Figure 1 , but they may be omitted in alternative systems, as discussed further below.

[0062] When Figure 1 When PH1 is executed in the system, the valve device is set in its second state (step 401), such as Figure 5A As shown. Therefore, the first fluid line 4a ("supply path") is closed, the bypass path is opened, and the passage from the supply path to the bypass path is opened. Figure 5AAs shown, the fluid is directed from line 4a via lines 20a, 20b to sewer 16 while passing through CRP sensor 22. PH1 includes steps 402-406. In step 402, pump P1 is operated to deliver water (fluid F1) from first container 3a to line 4a and lines 20a, 20b. Figure 5A 4, it is assumed that pumps P2, P3 are blocked and therefore inherently block lines 4b, 4c when not activated. If necessary, controllable on / off valves (not shown) can be arranged along fluid lines 4b, 4c to selectively block fluid flow. In step 403, pump P2 is operated to transfer concentrate (fluid F2) from the second container 3b into line 4a and lines 20a, 20b. Pump P2 can be activated simultaneously with pump P1 or after pump P1. Figure 5A The system 1 is shown when both pumps P1, P2 are operated during PH1. At this time, the mixture of F1 and F2 passes through the CRP sensor 22. In step 404, the signal S5 from the CRP sensor 22 is evaluated for determining a current CRP value and compared with a first target CRP value (TV1) defining the desired properties of the mixture of F1 and F2 as included in the dialysis fluid to be generated. TV1 may be predetermined and stored in the internal memory 32 of the control device 30 or set by an operator via the input device 34 (see Figure 1 ) input. Alternatively, the selected mixing ratio between F1 and F2 may be input by the operator and converted to TV1 by the control device 30. If the current CRP value is found to deviate from TV1, the speed of pump P1 and / or pump P2 is adjusted in step 405. Steps 404-405 are repeated until the current CRP value matches TV1. Thus, steps 404-405 define a tuning procedure. In some embodiments, it may be desirable to fix the fluid flow in the supply path during PH1. Figure 5A In the system shown, this can be achieved simply by adjusting only pump P2 in step 405. When the current CRP value matches TV1, a first weight change relation WCR1 is determined in step 406 by using signals S1, S2. WCR1 is part of the MCD and defines the weight change per unit time of container 3a. The weight change per unit time of container 3a The relationship between The weight change per unit time may be determined by operating any conventional differentiation algorithm on the respective signals S1, S2.

[0063] Subsequently, the method 400 proceeds to perform PH2, which includes steps 407-411. In step 407, pumps P1, P2 are operated according to signals S1, S2 to meet WCR1, and then the speeds of pumps P1, P2 are fixed. In step 408, pump P3 is operated to deliver B concentrate (fluid F3) from the third container 3c to the pipeline 4a and the pipelines 20a, 20b. Figure 5B The system 1 is shown when pumps P1, P2, P3 are operated during PH2. At this time, the mixture of F1, F2 and F3 passes through the CRP sensor 22. In step 409, the signal S5 from the CRP sensor 22 is evaluated for determining the current CRP value and compared with a second target CRP value (TV2) which defines the desired properties of the dialysis fluid to be generated. TV2 can be obtained similarly to TV1. If the current CRP value is found to deviate from TV2, the speed of the pump P3 is adjusted in step 410. Steps 409-410 define a tuning procedure corresponding to steps 404-405. Therefore, steps 409-410 are repeated until the current CRP value matches TV2. When the current CRP value matches TV2, a second weight change relationship WCR2 is determined in step 411 by using the signals S1, S2, S3. WCR2 is part of the MCD and defines the weight change per unit time of the container 3c according to the definition of TV2. and the weight change per unit time of container 3a and / or container 3b. Therefore, the relationship can be given as or

[0064] After PH2 is completed, the set values ​​for the dialysis treatment to be performed are obtained according to conventional practice (step 412). The set values ​​may, for example, define the flow rate of fresh dialysis fluid to the dialyzer 7 ("main flow rate"), UFR, UF, blood flow rate through the dialyzer 7, etc. The set values ​​may be retrieved from the internal memory 32 or entered by the operator via the input device 34 (see Figure 1 )enter.

[0065] In step 413, the system 1 operates according to the set value to generate dialysate. Step 413 can be performed directly after PH2 or at a later time. In step 413, pumps P1, P2, P3 are controlled based on signals S1, S2, S3 so as to achieve WCR1 and WCR2. In other words, pumps P1, P2, P3 operate at a speed that produces a weight change of containers 3a, 3b, 3c that satisfies WCR1 and WCR2. When WCR1 and WCR2 are met, dialysis fluid is generated. Step 413 can also include controlling pump P1 to supply dialysis fluid at a target flow rate given by the set value.

[0066] When step 413 is executed to generate the dialysis fluid, the valve device is set in its first state (step 414). Thereby, the line 4a ("supply path") is opened, and the passage from the line 4a to the bypass path is closed. In step 415, the pump P4 can be operated based on the signal S4 related to the signals S1-S3 to achieve the UFR according to the set value. Although in Figure 4 The pump P5 is not shown, but is operated to generate a blood flow rate according to a set value. The system 1 is thus operated to perform a dialysis treatment, such as Figure 3A shown.

[0067] It may be noted that, by definition, the system 1 is considered to generate dialysis fluid whenever it operates according to the mixing control data (MCD). Figure 4 In the example of , the dialysis fluid is generated by mixing three fluids, and the MCD includes WCR1 and WCR2. Therefore, in this example, whenever the system 1 is operated to achieve WCR1 and WCR2, the dialysis fluid is generated by the system 1. At all other times, the system is considered to generate a "mixture" of fluids, such as during the tuning procedure of PH1 and PH2.

[0068] In some embodiments, the dialysis treatment is initiated during dialysis treatment, for example, according to a schedule included in the set values ​​or by an operator during ongoing treatment via input device 34 ( Figure 1 ) to change the main flow rate. This can be achieved by jointly modifying the pumping speeds of the pumps P1, P2, P3 based on the signals S1-S3, so that WCR1 and WCR2 are met. In some embodiments, the valve device can be intermittently set in its second state to open the bypass path when the main flow rate is to be changed, so as to avoid that a mixture of F1, F2, F3 that does not meet the specifications of the dialysis fluid is delivered to the dialyzer 7 when the pumps P1-P3 are adjusted.

[0069] like Figure 4 As shown, method 400 may include a verification step 416, wherein the bypass path is intermittently opened during the ongoing dialysis treatment while pumps P1, P2, P3 are operated to deliver dialysis fluid through CRP sensor 22. Therefore, the dialysis treatment is inherently interrupted. In step 416, the CRP value is determined based on signal S5 and compared to TV2. If the CRP value matches TV2, the bypass path is closed and the dialysis treatment is thus resumed. If sufficient deviations are detected, method 400 may initiate execution of PH1 and PH2 to determine updated WCR1, WCR2. Alternatively, method 400 may terminate the dialysis treatment and / or terminate the dialysis treatment at the UI device ( Figure 1 35) in the example above generates an alarm for the operator.

[0070] The verification step 416 may be performed at regular intervals during treatment, or whenever a set value is changed during an ongoing treatment, or whenever a new container 3b, 3c of liquid concentrate has been installed. When a new container 3b, 3c has been installed, the method 400 may instead proceed directly to performing PH1 and PH2 without performing the verification step 416.

[0071] Alternatively or additionally, the verification step 416 may be performed whenever the speed of any of the pumps P1-P3 is found to deviate from an operating speed range. The operating speed range may be defined as a range of allowed speed values ​​for the respective pumps, or as an allowed variation of the speed of the respective pumps, e.g. relative to an initial speed of the respective pump when step 413 starts, i.e. when dialysis fluid is first generated at the target flow rate.

[0072] Whenever the bypass path is opened during an ongoing treatment, the control device 30 may be configured to estimate, based on the signals S1-S3, the amount of dialysis fluid delivered into the bypass path instead of being delivered to the dialyzer 7. This estimate may be given as the sum of the integral weight reductions in the signals S1-S3 over the time period in which the bypass path is open. This estimate may be deducted when the control device 30 calculates the cumulative amount of ultrafiltrate (UF) for the dialysis treatment.

[0073] like Figure 4 As shown, method 400 may include a protection step 417, in which the speed of pumps P1-P3 is evaluated relative to a set of speed limits for error detection. Errors in system 1, such as kinks in the fluid lines or mechanical failures of the pumps, may cause the speeds of the pumps to change significantly. The set of speed limits defines the maximum and / or minimum speed limits of the respective pumps. If the current speed of a pump is found to be below its minimum speed limit or above its maximum speed limit, step 417 may cause system 1 to shut down and / or cause an alarm to be generated via UI device 35.

[0074] Alternative embodiments of PH2 are possible. For example, in step 407, only one of pumps P1 and P2 is active. This means that steps 407-408 produce a mixture of F1 and F3, or F2 and F3, which is delivered through the CRP sensor 22 during the tuning procedure of steps 409-410. The obtained WCR2 defines the relationship or

[0075] The order in which the fluids F1-F3 are mixed in PH1 and PH2 can be selected in view of the required or available measurement range (calibration range) of the CRP sensor 22. The measurement range represents the range of CRP values ​​that can be measured by the sensor 22 with sufficient accuracy. An inexpensive CRP sensor 22 may have a very narrow available measurement range. In order to minimize the required measurement range, the order of the fluids may be selected to minimize the difference between TV1 and TV2. For example, if the conductivity is measured by the CRP sensor 22, then if PH1 is performed on a mixture of water and A concentrate (F1, F2), and PH2 is performed on a mixture of water, A concentrate and B concentrate (F1, F2, F3), that is, as Figure 4 As shown, the minimum measuring range is obtained.

[0076] like Figure 4 As shown by the dashed arrows in , the method 400 can return to the preparation phases PH1, PH2 at any time to make a new determination of the MCD. As described above, this new determination can be triggered by the verification step 416. In another example, when the composition of the medical fluid is changed, for example based on user input or according to a predetermined schedule, the method 400 can return to PH1 and PH2. The change in composition is given by a change in TV1 and / or TV2 (see steps 404, 409).

[0077] Figure 6-7 An alternative installation of a CRP sensor 22 in a bypass path in a system for dialysis treatment is shown. Figure 6 The system and Figure 1 The system in FIG. 1 differs in that the bypass path is defined by a bypass line 20 extending from line 4a to sewer 16. A CRP sensor 22 is arranged in bypass line 20, and valve device 21b is omitted since it does not play a role therein. As shown, the CRP sensor 22 can be releasably connected to a connector 19f, which is included in the disposable component (see FIG. 1 ). Figure 2A ). Figure 7 The system and Figure 1 The system in is different in that the CRP sensor 22 is located in the bypass line 20a. As shown, the CRP sensor 22 can be releasably connected to the connectors 19f, 19g included in the disposable component. Figure 6-7 The system in Figure 1 A technical advantage of the system in is that the CRP sensor 22 is not exposed to the effluent. This can further extend the operational life of the CRP sensor 22 and / or reduce the need for flushing, disinfection or other maintenance. On the other hand, when the CRP sensor 22 is exposed to the effluent, the signal S5 can be processed during a dedicated operating sequence of the system to evaluate the efficacy of the dialysis treatment, for example, according to patent documents US5024756 or US6217539.

[0078] In the system shown herein, it may be desirable to ensure that the fluid is thoroughly mixed in the supply path (line 4a) upstream of its connection to the bypass. Thus, it is ensured that the fluid mixture reaching the CRP sensor 22 is homogeneous, regardless of how far downstream the CRP sensor 22 is located in the bypass path.

[0079] As described above, the control device 30 may be configured to control the speed of the pumps P1-P3 based on the signals S1-S3 from the scales 2a-2c. To this end, the control device 30 may implement any conventional feedback control, including but not limited to P, PI or PID control. If the time constant of the scales 2a-2c is large, which causes the scales to respond slowly to weight changes, the dynamic performance may be improved by so-called cascade control, which is well known to those skilled in the art.

[0080] It should be understood that the dialysis fluid can be generated by mixing any number of fluids. Thus, the system described herein may include one or more additional containers of liquid concentrate arranged on respective scales, and Figure 4 The method in can be extended to have one or more additional preparation stages for determining the weight change ratio. Likewise, the dialysis fluid can be generated by mixing only two fluids, which means that PH2 is omitted in method 400 and step 413 is modified to operate only pumps P1 and P2 to achieve WCR1 given by PH1.

[0081] It can also be noted that the amount of effluent delivered from the dialyzer 7 does not need to be monitored by using a scale 2d. Instead, a flow meter or a positive displacement pump can be used to monitor the amount of effluent. Thus, instead of collecting the effluent in a container 3d, the effluent can be directed directly to the sewer 16 or to a reservoir whose weight is not monitored.

[0082] exist Figure 1 In other variations of system 1, the bypass path is omitted, and thus also the Figure 4 401, 414 and 417 in the method. If it is considered not harmful to the patient, the mixture can be pumped along the supply path (line 4a) and through the dialyzer 7 instead of being pumped into the bypass path during PH1 and PH2. After passing through the dialyzer 7, the mixture can be collected in the container 3d or transferred from the effluent line 12 to a dedicated discharge line extending to the sewer 16. In such a variation, the CRP sensor 22 will be located in the effluent line 12 or in a dedicated line. In another variation, line 4a is disconnected from the dialyzer 7 during PH1 and PH2, but is connected to the CRP sensor 22, during Figure 1 In the example of , connector 19d will be temporarily released from the dialyzer 7 and attached to the CRP sensor 22 instead of connector 19f.

[0083] Figure 4 The method is not limited to HD but can be applied to any RRT system, including any mode of extracorporeal blood therapy and PD. Fig.12 A system 1' is shown for generating a medical fluid for any type of RRT. The system 1' does not have to be part of a system for dialysis treatment. The system 1' shown is configured to generate a medical fluid by mixing two fluids F1, F2, but can be extended to mix further fluids if required. Figure 1 and Fig.12 The same components are used in the same reference numerals. The description of these components will not be repeated. Fig.12 In the embodiment, the outlet of the first fluid line 4a (supply path) includes a connector 19d, which is connected to the connector 40a of the receiving device 40. The system also includes a control device (not shown) configured to perform at least PH1 and Figure 4 Step 413 of method 400. Fig.12 The system in the embodiment includes a bypass path represented by the bypass line 20, so the control device can also perform steps 401 and 414 and the verification step 416. The receiving device 40 is arranged to receive the medical fluid generated by performing step 413. In some embodiments, the medical fluid is a dialysis fluid for extracorporeal blood treatment, such as HD or HDF, and the receiving device 40 includes a dialyzer 7 ( Figure 1 In some embodiments, the medical fluid is a replacement fluid for HF or HDF, and the receiving device 40 includes an extraction line 8a and / or a return line 8b ( Figure 1 ) on an infusion port. In some embodiments, the medical fluid is a dialysis fluid for PD, and the receiving device 40 includes a disposable fluid circuit that is attached to the PD cycler. It is also conceivable that the receiving device 40 also corresponds to the peritoneal cavity. In some embodiments applicable to all types of RRT, the receiving device 40 is a reservoir for collecting medical fluid for subsequent use in the RRT. In such embodiments, the medical fluid is not generated on demand. The reservoir may or may not be connected to the system for the dialysis treatment, or be part of the dialysis treatment system.

[0084] In some embodiments, the system 1 ' is comprised in a separate fluid generating device arranged to supply medical fluid to a dialysis machine.

[0085] Fig.12 The system 1' in can be composed of disposable components and machine components, similar to Figure 1While significant technical advantages are obtained by confining the generation of medical fluids to disposable components, the systems 1 , 1 ′ may also be implemented to generate medical fluids within permanent structures.

[0086] In some embodiments, some or all of the fluid lines in the disposable components are configured as channels in an integral cassette. The pump and / or valve device may or may not be integrated into the cassette. If integrated, the pump may, for example, be implemented as a diaphragm pump.

[0087] In a further alternative, the containers 3b, 3c may be refillable by being fluidly connected to respective sources of liquid concentrate.

[0088] In the systems 1, 1' shown in the figures, the pump P1 is located in or on the first fluid line 4a downstream of the connector 6' (and the connector 6", if present). Therefore, the first pump P1 not only extracts the fluid F1 from the container 3a, but also defines the flow rate of the medical fluid ("mainstream rate"). This provides the technical advantage of simplifying the regulation of the mainstream rate. However, in some embodiments, the pump P1 may alternatively be located upstream of the connector 6'.

[0089] In some embodiments not shown, the system 1, 1' further comprises one or more sterilizing grade filters, for example in the first fluid line 4a downstream of the connector 6' (and / or connector 6", if present). Preferably, the filter is arranged close to the outlet of the medical fluid, for example between the valve device 21a and the connector 19d. The filter can be configured to ensure that the medical fluid meets the standards of ultrapure dialysis fluid or replacement fluid in terms of live bacteria (sterility) and endotoxins. Such filters are well known in the art.

[0090] For the reasons described above, the CRP sensor 22 can have a long operating life. In particular, the operating life of the CRP sensor 22 can exceed that of the disposable component 1a ( Figure 2A ) operating life. Thus, it can be seen that the CRP sensor 22 is "reusable". To enable reuse, the disposable component is configured to be releasably attached to the CRP sensor 22. In the example shown, the disposable component includes one or more terminal connectors for establishing a releasable fluid connection to the CRP sensor 22 (see Figure 1 , 6 , 19f in 7 and 12, and Figure 7 19g in it).

[0091] In some embodiments, the system includes an auxiliary CRP sensor in addition to the reusable CRP sensor 22. In some embodiments, the auxiliary CRP sensor is a disposable component. Fig.12In the embodiment of the present invention, the disposable CRP sensor 122 is arranged in the pipeline 4a upstream of the valve device 21a. The disposable sensor 122 can be part of a disposable component, which can be configured by analogy with Figure 2A The disposable component 1a described above is used to define the fluid path of the system. The disposable sensor 122 can be discarded with the disposable component. The disposable sensor 122 is a low-end sensor device. Although relatively cheap, such sensor devices generally have poor performance in terms of accuracy and / or precision, which makes them unsuitable for determining MCD. The purpose of the disposable sensor 122 is to detect changes in the composition of the medical fluid as it is generated by step 413. Such changes may be harmful to the patient and may be caused by errors in the concentrate or water supply, for example by an operator manipulating the contents of the concentrate container. Therefore, the control device can be configured to execute a safety procedure when the medical fluid is being generated. The safety procedure assumes that the signal drift of the disposable sensor 122 is small during its operation. Fig.13A An example safety procedure 1300 is shown in . In the safety procedure, a CRP value is obtained from the disposable sensor 122 (step 1301) and evaluated (step 1302) for detecting a deviation, which indicates a change in composition. When such a deviation is detected (step 1303), the control device takes a dedicated action (step 1304). The dedicated action may include, for example, performing a verification step 416, shutting down the system 1', generating an alarm, etc., depending on the size of the deviation. In order to improve the performance of the disposable sensor 122, the control device may also perform a calibration procedure, for example when generating a medical fluid according to step 413. In . Fig. 13BAn example calibration procedure 1310 is shown in FIG. 1310 . In the calibration procedure 1310 , if the bypass path is not already open, the control device opens the bypass path (step 1311 ). Subsequently, the control device obtains ( 1312 ) a first set of CRP values ​​from the signal S5 of the sensor 22 and obtains ( 1313 ) a second set of CRP values ​​from the signal S5′ of the disposable sensor 122 (step 1313 ). Steps 1312-1313 assume that the first and second sets of CRP values ​​represent the same fluid, such as a medical fluid or any intermediate mixture (see below). The first and second sets of CRP values ​​may, but need not, be obtained simultaneously. Assuming that the first set of CRP values ​​is correct, the control device processes (step 1314 ) the first and second sets of CRP values ​​to determine a calibration factor for the disposable sensor 122 . The calibration factor is given by one or more parameter values ​​of a conversion function that converts a CRP value measured by the disposable sensor 122 into a corresponding CRP value measured by the sensor 22 . For example, the calibration factor may include an offset value (positive or negative) to be added to the CRP value from the disposable sensor 122 . The control device terminates the calibration procedure 1310 by storing the calibration factor in memory and closing the bypass path to begin sending medical fluid to the receiving device 40 .

[0092] Steps 1312-1313 may be performed at least in part during a tuning procedure. Figure 4 In the example of , the first set of CRP values ​​may include one or more CRP values ​​measured at or after the end of the preparation phase PH2, i.e., when the current CRP value matches the target value TV2 (see step 409). Figure 4In the example of , when the current CRP value matches the target value TV1 (see step 404), step 1312 can also be performed at the end of or after the preparation phase PH1. Therefore, if the medical fluid is generated by mixing more than two component fluids, steps 1312-1313 can be performed to obtain not only the CRP value of the medical fluid, but also the CRP value of one or more intermediate mixtures generated during the tuning procedure. The use of intermediate mixtures expands the range of CRP values ​​in the first group and the second group. By considering a wider range of CRP values ​​near the target value of the medical fluid, the accuracy of the calibration factor can be improved. For example, in step 1314, the relationship between the first CRP value and the second CRP value within the range can be, for example, fitted to a line representing the match between the first CRP value and the second CRP value by a linear least squares fit. In this fitting, the CRP value can be weighted or unweighted, for example, so as to relatively increase the impact of the CRP value measured for the medical fluid compared to the CRP value measured for the intermediate mixture. The fitting produces the above-mentioned conversion function, and therefore also produces the calibration factor. Furthermore, since the transfer function is determined for a range of CRP values, the transfer function also defines the calibration factor to be applied in the safety procedure 1300 if the target value of the medical fluid (TV2) changes within this range, which would occur if the composition of the medical fluid changes.

[0093] like Fig.13A As shown in step 1302A in , the control device can be configured to obtain and apply a calibration factor during the safety procedure to correct the CRP value from the disposable sensor 122 before evaluating the thus corrected CRP value for detecting deviation. The calibration procedure 1310 is facilitated by positioning the disposable sensor 122 in the main supply path so that it is exposed to the medical fluid, and upstream of the diversion from the main fluid path to the bypass path (control valve 21a), so that the sensors 22, 122 are exposed to the medical fluid at the same time. However, it is contemplated that the disposable sensor 122 is instead located downstream of the control valve 21a, and the control device obtains (in step 1312) a first set of CRP values ​​when the bypass path is open, and obtains a second set of CRP values ​​when the bypass path is closed.

[0094] Figure 8 800 is a flow chart of an example method 800 for configuring and operating a system to generate a medical fluid. The method 800 may be performed by a control device in any of the systems described herein. In step 801, a user (operator) is caused to install a disposable component on a machine component, appropriately engaged with a scale, pump, etc. The machine component may be a dialysis machine or any other machine equipped with the required pumps, scales, etc. In step 802, the user is caused to connect the disposable component to the reusable CRP sensor 22, such that the reusable CRP sensor 22 is included in the bypass path. Subsequently, execution Figure 4 Method 400 is performed to generate a medical fluid. At a particular point in time, method 400 terminates and step 803 is executed to begin a procedure for ensuring reuse of CRP sensor 22. An example of step 803 is described below. When step 803 is completed, step 804 is executed to enable a user to remove the disposable component from the machine component and discard the disposable component. It is conceivable that in step 804, a subset of the disposable components are reusable and are left on the machine component. For example, if containers 3b, 3c are included in the disposable component, then containers 3b, 3c can be left on scales 2b, 2c. Steps 801-804 may be included in the UI device 35 ( Figure 1 ) provides user instructions on the user to enable the user to perform one or more actions. Therefore, in the context of the present disclosure, enabling the user to perform an action is equivalent to outputting instructions to the user to perform the action.

[0095] Step 803 may vary depending on the location and level of integration of the CRP sensor 22 within the system.

[0096] In some embodiments, the CRP sensor 22 is integrated into the water supply 17. An example of such a supply 17 is Fig. 9 . The operation of the water supply device 17 is controlled by an internal controller (not shown). The device 17 includes a water treatment unit 90, which can be operated to treat incoming water to produce purified water for medical fluids. The water treatment unit 90 can be configured to purify the incoming water by any available technology, such as a sediment filter, a carbon filter, a resin bed, ultrafiltration (UF), reverse osmosis (RO), nanofiltration, electrodeionization (EDI) or capacitive deionization (CDI). The device 17 includes a water supply line 91 extending from an inlet connector 91a to an outlet connector 91b. In operation, a tap water source can be connected to the inlet connector 91a, and the terminal connector 19a ( Figure 1 and Fig.12 ) can be connected to the outlet connector 91b. The device 17 also includes an auxiliary fluid line 92, which extends from the inlet connector 92a to the outlet connector 92b via the sensor 22. In operation, the terminal connector 19f ( Figure 1 , 6, 7 and 12) can be connected to the inlet connector 92a, and the fluid line (not shown) extending to the sewer 16 can be connected to the outlet connector 92b. The device 17 also includes a cleaning unit 93, which can be operated to perform a cleaning operation on the sensor 22 and optionally the water treatment unit 90. The cleaning operation may include flushing and / or disinfection. As used herein, flushing involves flushing the CRP sensor with a fluid to remove sediment, particles, etc. The fluid can be any liquid, including water, and may or may not include a cleaning agent, such as a detergent, a descaling agent, etc. As used herein, disinfection refers to a process to prevent the growth of microorganisms in the CRP sensor, and may involve heat treatment, flushing with a disinfectant or sterilant, etc. It should be understood that in the cleaning operation, not only the CRP sensor 22 is processed, but also the fluid path is connected. The device 17 also includes an I / O unit 94, which can be operated to output a signal S5 and optionally receive a control signal. In operation, the I / O unit 94 is connected to the control device 30 by wire or wirelessly. In one embodiment of step 803, the control device 30 transmits a control signal to the supply device 17 to start the cleaning operation. In another embodiment of step 803, the control device 30 enables the user to control the supply device 17 via the UI device 35 ( Figure 1 ) starts the cleaning operation, for example by pressing a dedicated button (not shown) on the device 17.

[0097] Because the CRP sensor 22 is located in the bypass path, there is a smaller risk factor for microbial growth in the CRP sensor 22 than when the CRP sensor 12 is arranged in the main supply path (line 4a). Therefore, the need for disinfection is reduced or even eliminated. However, because the CRP sensor 22 is reused over multiple treatment sessions, periodic cleaning may be performed to ensure that the CRP sensor 22 operates properly over time. For example, flushing may be performed to reduce fouling, such as by scaling, deposition, etc. Whenever there is a risk of microorganisms moving along the bypass path into the main supply path, cleaning to prevent microbial growth in the CRP sensor 22 may be important. For example, such risk may depend on the distance from the CRP sensor 22 to the main supply path and / or whether the bypass path is intermittently opened when the medical fluid is generated (see verification step 416). It will be appreciated that the cleaning operation may involve flushing and / or disinfection, and that flushing and disinfection may be performed at different time intervals. In addition, in contrast to Figure 8 Unlike method 800 in FIG. 8 , it is contemplated that cleaning operations may be performed less frequently than after every treatment session.

[0098] In some embodiments, the CRP sensor 22 is integrated in the machine component 1b (see Figure 2B). If the machine component comprises an integrated cleaning unit for cleaning the sensor 22 , the control device 30 can autonomously start the cleaning operation in step 803 .

[0099] In some embodiments, the CRP sensor 22 is included in a separate device (not shown) that may or may not be attached to the machine component 1 b or the supply device 17 .

[0100] Figures 10A-10B An example of a CRP sensor 22 is shown, which is arranged inside a device 100, which may be a machine part 1b, a supply device 17, or a separate device as described above. Here, it is assumed that the device 100 lacks the function of flushing or disinfecting the sensor 22. The sensor 22 defines an internal channel 22' and is configured to measure the CRP value of the fluid in the channel 22'. The device 100 defines an inlet port 23a and an outlet port 23b, which are in fluid communication with the channel 22' on the flow path 23. Although not shown, the device 100 includes an I / O unit for transmitting measurement data (see signal S5) to the control device 30. Fig. 10A shows a first connection state, which is Figure 8 In step 802 of . In the first connection state, the sensor 22 is arranged in the bypass path. In the example shown, the bypass path includes a first interconnectable pipeline section and a second interconnectable pipeline section 20b1, 20b2, which together correspond to Figure 1 Pipeline 20b, Figure 6 or Fig.12 Pipeline 20 or Figure 7 Specifically, the pipeline section 20b2 includes a terminal connector 19f configured to be connected to the inlet port 23a and a terminal connector 20c2 configured to be connected to the terminal connector 20c1 on the pipeline 20b1. In addition, the pipeline section 20c is connected to the outlet port 23b through the terminal connector 20c3 and extends to the sewer 16. Fig. 10B The second connection state is shown. Figure 8803. In the second connection state, the sensor 22 is encapsulated in a closed loop and filled with a dedicated fluid, which is configured to extend the operating life of the sensor 22. For example, the dedicated fluid can be an antibacterial fluid. The antibacterial fluid includes an antibacterial agent, which is a biological or chemical agent (also called a bactericide) that can stop bacterial growth or even kill bacteria. Therefore, in the second connection state, the sensor 22 is maintained in an environment that prevents bacterial growth. In order to obtain the second connection state, step 803 may include operating the system 1, 1' to transport the dedicated fluid from the supply source to the bypass path and pass through the sensor 22. When the sensor channel 22' contains a dedicated fluid that can be detected according to the signal S5, step 803 includes instructing the user to disconnect the pipeline 20b1 from the pipeline 20b2, disconnect the pipeline 20c from the port 23b, and attach the terminal connector 20c2 to the port 23b. Through this manipulation, the dedicated fluid is maintained in the sensor 22. Figures 10A-10B The manipulation in step 802 may include reusing a portion of the disposable component to fluidically connect ports 23a, 23b. When method 800 is performed later, when device 100 is in the second connection state, step 802 may include instructing the user to disconnect and discard tubing segment 20b2 ( Fig. 10A ).

[0101] The dedicated fluid may be different from fluids F1, F2, F3 and may be delivered to the bypass path from a separate source by a dedicated pump. However, in some embodiments, the dedicated fluid comprises at least one liquid concentrate contained in the medical fluid. For example, A concentrate has bacteriostatic properties and may be used as the dedicated fluid in step 803. Figure 1 , valve means 21a, 21b may be set in their second state, pump P3 may be stopped and pumps P1, P2 may be operated at the same speed to deliver A concentrate to sensor 22. It will be appreciated that the ability to use one of the liquid concentrates as the dedicated fluid in step 803 greatly simplifies the construction of system 1, 1'.

[0102] Figures 10A-10B Only one example of how to manipulate the sensor 22 to keep the special fluid in the sensor is shown. For example, the ports 23a, 23b can be sealed in other ways to keep the special fluid. In addition, if the sensor 22 is integrated in the machine part 1b or the supply device 17, the technique of keeping the special fluid in the sensor 22 in step 803 is also applicable.

[0103] Fig.11 is a flow chart of an example method 1100 that may be performed during the generation of a medical fluid in the system 1, 1'. The method 1100 will refer to Fig.121 ' is described in detail. When an interruption in the operation of the receiving device 40 is detected (step 1101), the valve device 21a is operated to open the bypass path to guide the medical fluid to the sewer 16 (step 1102). Here, it is assumed that the interruption prevents the device 40 from receiving the medical fluid. The control device of the system 1' can detect the interruption based on an output signal from the receiving device 40 or from a sensor, such as a pressure sensor (not shown) in the pipeline 4a. In conjunction with step 1102, in order to minimize the waste of the liquid concentrate F2, at least the speed of the pump P2 is reduced but not stopped (step 1103). Therefore, the two pumps P1 and P2 are still operable. When the resumption of operation of the receiving device 40 is detected (step 1104), the speeds of the pumps P1 and P2 are controlled to meet the target flow rate and achieve WCR1 (step 1105). In conjunction with step 1104, the valve device 21a is operated to close the bypass path to guide the medical fluid toward the receiving device 40 (step 1106). It is conceivable that step 1104 is implemented using a timeout function which causes the system 1 ′ to shut down if no recovery operation is detected within a predetermined time from step 1101 .

[0104] By means of the method 1100, during the interruption of the receiving device 40, the pumps P1, P2 remain in operation. If the pumps P1, P2 were stopped, hysteresis effects might require the control device to restart PH1 to update WCR1. It is conceivable that in step 1103, both pumps P1, P2 are operated to reduce their speeds. Furthermore, when operating at a reduced speed, the pumps P1, P2 can be controlled to maintain WCR1 in view of the signals S1, S2. Therefore, in step 1103, medical fluid is still generated, albeit at a reduced flow rate. This allows the control device to verify, based on the signal S5, that the CRP value satisfies TV1 during the entire interruption, and will also further reduce the risk of hysteresis effects.

[0105] Commercially available concentrates may be used in the fluid generating system 20 described herein.

[0106] In some embodiments, by mixing a single concentrate with water at a dilution ratio of 10-50 by volume, a dialysis fluid for treating a CKD patient by hemodialysis, hemofiltration or hemodiafiltration therapy is generated. In a non-limiting example, a single concentrate comprises lactate, sodium, potassium, calcium, magnesium, glucose and chloride. Such a concentrate can be purchased, for example, from the PureFlow SL system of NxStage. Alternatively, a dialysis fluid can be generated by mixing two concentrates with water. For example, a bicarbonate concentrate and an acid concentrate can be mixed with water at a dilution ratio of 10-50. Such a concentrate is commercially available and is well known in the art. In a non-limiting example, a bicarbonate concentrate comprises bicarbonate, and an acid concentrate comprises sodium, potassium, calcium, magnesium, glucose, acetate and chloride. In some acid concentrates, acetate is replaced or supplemented by another acid such as citric acid or hydrochloric acid.

[0107] In some embodiments, a dialysis fluid for CRRT treatment of AKI patients is generated by mixing at least one concentrate with water. In a non-limiting example, the dialysis fluid includes bicarbonate, sodium, potassium, calcium, magnesium, phosphate, glucose, acetate and chloride. In one example, an alkali concentrate and an electrolyte concentrate can be mixed with water to form a dialysis fluid. For example, the alkali concentrate can be an alkaline bicarbonate solution, and the electrolyte concentrate can be an acidic glucose-based electrolyte solution.

[0108] In some embodiments, the dialysis fluid for peritoneal dialysis (PD) is generated by mixing at least one concentrate with water. Exemplary compositions of PD concentrates to be mixed with water alone or in combination are disclosed in patent documents US2018 / 0021501 and WO2017 / 193069, which are incorporated herein by reference.

[0109] While the disclosed subject matter has been described in connection with what are presently considered to be the most practical embodiments, it is to be understood that the disclosed subject matter is not limited to the disclosed embodiments, but on the contrary is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the appended claims.

[0110] Further, while operations are depicted in the drawings in a particular order, this should not be understood as requiring that such operations be performed in the particular order shown or in sequential order, or that all illustrated operations be performed, to achieve desirable results.

[0111] Hereinafter, clauses are recited to summarize some aspects and embodiments as disclosed above.

[0112] C1. A computer-implemented method for generating a medical fluid for renal replacement therapy, the method comprising: operating (402) a first pump (P1) to deliver a first fluid (F1) from a first container (3a) arranged on a first scale (2a) to a supply path (4a), the supply path extending to an outlet (19d) of the medical fluid; operating (403) a second pump (P2) to deliver a second fluid (F2) from a second container (3b) arranged on a second scale (2b) to the supply path (4a), so as to generate a mixture of the first fluid and the second fluid (F1, F2) in the supply path (4a); measuring (404) a component-related parameter of the mixture by a sensor (22); adjusting (405) the ... and the pumping speed of at least one of the second pumps (P1, P2) until the sensor (22) measures a target value of the component-related parameter; when the sensor (22) measures the target value, based on the first output signal and the second output signal (S1, S2) from the first scale (2a, 2b), determining (406) the relationship between a first weight change of the first scale (2a) and a second weight change of the second scale (2b); and generating (413) the medical fluid in the supply path (4a), the generating (413) comprising operating the first pump and the second pump (P1, P2) based on the first output signal and the second output signal (S1, S2) to achieve the relationship between the first weight change and the second weight change.

[0113] C2. The method according to C1, wherein the first pump and the second pump (P1, P2) are operated simultaneously to deliver the first fluid and the second fluid (F1, F2) into the supply path (4a).

[0114] C3. The method according to C1 or C2 also includes: before the measurement (404), operating (401) a valve device (21a, 21b) to redirect the mixture from the supply path (4a) to a bypass path (20, 20a, 20b) that guides the mixture through the sensor (22).

[0115] C4. The method according to C3 further includes: when medical fluid is generated in the supply path (4a), operating (414) the valve device (21a, 21b) to guide the medical fluid along the supply path (4a) to an outlet (19d) of the medical fluid.

[0116] C5. A method according to C3 or C4, wherein the medical fluid is generated in the supply path (4a) upstream of a connection point where the bypass path (20, 20a, 20b) joins the supply path (4a).

[0117] C6. A method according to C4 or C5, wherein the outlet (19d) is connected to a receiving device (40), and the method further comprises: when the medical fluid is guided to the outlet (19d) along the supply path (4a), detecting (1101) an interruption operation of the receiving device (40); and, when the interruption operation is detected, operating (1102) the valve device (21a, 21b) to close the supply path (4a) and open the bypass path (20, 20a, 20b), and reducing (1103) the pumping speed of at least one of the first pump and the second pump (P1, P2).

[0118] C7. The method according to C6, wherein the reducing (1103) further comprises maintaining the relationship between the first weight change and the second weight change.

[0119] C8. The method according to any one of C3 to C7 further includes: before operating (402) the first pump (P1) and operating (403) the second pump (P2), enabling (802) a user to connect the bypass path (20, 20a, 20b) fluid to the sensor (22).

[0120] C9. The method according to C8 also includes: after completing renal replacement therapy, starting (803) a procedure for ensuring the reuse of the sensor (22).

[0121] C10. A method according to C9, wherein the procedure for ensuring reuse includes at least one of the following: a) operating a fluid supply device (17, 1b) including a sensor (22) to perform an operation to flush and / or disinfect the sensor (22), or b) delivering a special fluid to the sensor (22) through a bypass path (20, 20a, 20b) and enabling a user to disconnect the bypass path (20, 20a, 20b) from the sensor (22) and manipulate the sensor (22) to keep the special fluid within the sensor (22).

[0122] C11. The method according to C10, wherein the dedicated fluid is bacteriostatic.

[0123] C12. A method according to C10 or C11, wherein the delivery of the dedicated fluid includes: operating a second pump (P2) to deliver the second fluid (F2) to the sensor (22) via a supply path (4a) and a bypass path (20, 20a, 20b), or operating a third pump (P3) to deliver a third fluid (F3) to the sensor (22) via a supply path (4a) and a bypass path (20, 20a, 20b), wherein the third fluid (F3) is included in the medical fluid together with the second fluid (F2).

[0124] C13. A method according to any of the preceding clauses, wherein the supply path (4a) is discarded after completion of renal replacement therapy.

[0125] C14. A method according to any of the preceding clauses, wherein the generating (413) of the medical fluid comprises: controlling the pumping speeds of the first pump and the second pump (P1, P2) to generate the medical fluid at a target flow rate while maintaining the relationship between the first weight change and the second weight change.

[0126] C15. A method according to C14, wherein the target flow rate matches the consumption rate of the medical fluid of the renal replacement therapy.

[0127] C16. The method according to any of the preceding clauses, wherein the first fluid (F1) is water and the second fluid (F2) is a liquid concentrate.

[0128] C17. A method according to C16, wherein the adjustment (405) includes: adjusting the pumping speed of the second pump (P2) until the sensor (22) measures a target value of the composition-related parameter.

[0129] C18. The method according to any of the preceding clauses further comprises: when generating the medical fluid in the supply path (4a), monitoring (416, 417) the pumping speeds of the first pump and the second pump (P1, P2) for detecting changes indicative of an operating error.

[0130] C19. The method according to any of the preceding clauses, further comprising: activating (408) a third pump (P3) to deliver a third fluid (F3) from a third container (3c) arranged on a third scale (2c) into the supply path (4a), while operating the first pump (P1) to deliver the first fluid (F1) into the supply path (4a) and / or operating the second pump (P2) to deliver the second fluid (F2) into the supply path (4a), so as to generate another mixture in the supply path (4a); measuring (409) a component-related parameter of the another mixture by means of a sensor (22); and adjusting (410) the pumping speed of the third pump (P3) until the sensor (22) measures another target value of the ingredient-related parameter; and when the sensor (22) measures the other target value, based on a third output signal (S3) from the third scale (2c), determining (411) another relationship between a third weight change of the third scale (2c) and at least one of the first weight change and the second weight change, wherein the generating (414) includes operating the third pump (P3) based on the third output signal (S3) to achieve the other relationship between the third weight change and the at least one of the first weight change and the second weight change.

[0131] C20. A method according to C19, wherein, during the adjustment (410), the first pump and the second pump (P1, P2) are operated simultaneously to deliver the first fluid and the second fluid (F1, F2) into the supply path (4a), and the pumping speeds of the first pump and the second pump (P1, P2) are fixed to achieve the relationship between the first weight change and the second weight change.

[0132] C21. A method according to any of the preceding clauses, wherein the composition-related parameter represents the conductivity, resistivity or concentration of one or more solutes, or pH.

[0133] C22. A method according to any of the preceding clauses, wherein the medical fluid is a treatment fluid for use in extracorporeal blood treatment or peritoneal dialysis treatment.

[0134] C23. A control device, comprising: a circuit (31, 32) configured to execute a method according to any one of C1-C22; and a signal interface (33a) configured to output control signals (C1, C2) for a first pump and a second pump (P1, P2) and further configured to receive a first output signal and a second output signal (S1, S2) from a first scale and a second scale (2a, 2b) and a sensor signal (S5) representing a component-related parameter from the sensor (22).

[0135] C24. A computer-readable medium comprising computer instructions which, when executed by a processor (31), enable the processor (31) to perform a method according to any one of C1-C22.

[0136] C25. A system for generating a medical fluid for renal replacement therapy, the system comprising: a first scale (2a); a first container (3a) arranged on the first scale (2a); a second scale (2b); a second container (3b) arranged on the second scale (3b); a supply path (4a) configured to receive a first fluid (F1) from the first container (3a) and a second fluid (F2) from the second container (3b), and extending to an outlet (19d) for the medical fluid; a first pump (P1) arranged to deliver the first fluid (F1) from the first container (3a) to the supply path (4a); a second pump (P2) arranged to deliver the second fluid (F2) from the second container (3b) to the supply path (4a) to generate a mixture of the first fluid and the second fluid (F1, F2) in the supply path (4a); a sensor (22) configured to measure component-related parameters; and a control device (30) according to C23.

[0137] C26. A system according to C25, wherein the sensor (22) is reusable.

[0138] C27. The system according to C25 or C26 further includes: a bypass path (20, 20a, 20b), which is fluidically connected to the supply path (4a) and extends to the sensor (22); and a valve device (21a, 21b) which is operable to selectively direct the mixture from the supply path (4a) to the bypass path (20, 20a, 20b).

[0139] C28. The system according to C27 further includes an auxiliary sensor (122), which is configured to measure component-related parameters and is arranged in the supply path (4a), wherein the control device (30) is configured to execute a safety procedure (1300) when the medical fluid is generated in the supply path (4a), wherein the safety procedure (1300) includes: obtaining a measurement value representing the medical fluid from the auxiliary sensor (112), evaluating the measurement value for deviation detection, and performing a special action when a deviation is detected.

[0140] C29. A system according to C28, wherein the auxiliary sensor (122) is a disposable component.

[0141] C30. A system according to C28 or C29, wherein the control device (30) is further configured to execute a calibration procedure (1310) when a medical fluid is generated in the supply path (4a), wherein the calibration procedure (1310) includes: operating the valve device (21a, 21b) to guide the medical fluid from the supply path (4a) to the bypass path (20, 20a, 20b), obtaining a first set of measurement values ​​representing the medical fluid from the sensor (22), obtaining a second set of measurement values ​​representing the medical fluid from the auxiliary sensor (122), and calculating a calibration factor based on the first set of measurement values ​​and the second set of measurement values, wherein the control device (30) is configured to adjust the measurement value by the calibration factor in the safety procedure (1300) before evaluating the measurement value.

[0142] C31. A system according to any one of C27 to C30, comprising a machine part (1b) and a disposable device (1a) releasably engaged with the machine part (1b), wherein the machine part (1b) comprises a first scale and a second scale (2a, 2b), a first pump and a second pump (P1, P2) and a valve device (21a, 21b), and wherein the disposable device (1a) defines a supply path (4a) and a bypass path (20, 20a, 20b).

[0143] C32. A system according to any one of C27 to C31, wherein the sensor (22) is releasably connected to the bypass path (20, 20a, 20b).

[0144] C33. A system according to any one of C27 to C32, which can be operated to deliver a dedicated fluid to a sensor (22) through a bypass path (20, 20a, 20b), and instruct a user to disconnect the bypass path (20, 20a, 20b) from the sensor (22) and manipulate the sensor (22) to keep the dedicated fluid within the sensor (22).

[0145] C34. A system according to C33, wherein the dedicated fluid includes a second fluid (F2) and / or a third fluid (F3), the dedicated fluid is optionally included in the medical fluid, and wherein the dedicated fluid is bacteriostatic.

[0146] C35. A system according to any one of C27 to C34, wherein the sensor (22) is included in a fluid supply device (17), which is configured to supply a first fluid (F1) and is fluidically connected to the first container (3a).

[0147] C36. A system according to C35, wherein the fluid supply device (17) can be operated to perform a flushing and / or disinfection procedure of the sensor (22).

[0148] C37. A system according to any one of C25 to C36, wherein a connecting line (4b) extends from the second container (3a) to a connector (6') on the supply path (4a), and a second pump (P2) is arranged in or on the second connecting line (4b) to transport a second fluid (F2) from the second container (3a) to the supply path (4a), and wherein the first pump (P1) is arranged in or on the supply path (4a) between the connector (6') and an outlet (19d) of the medical fluid.

[0149] C38. A disposable device for use in a system as described in any one of claims 27 to 38, the disposable device comprising: a first container (3a); a supply path (4a); a connecting line (4b) which is fluidically connected to the supply path (4a) and extends to a first terminal fluid connector (19b), the first terminal fluid connector being configured for connection to a second container (3b); and a bypass path (20, 20a, 20b) which extends from the supply path (4a) to a second terminal fluid connector (19f), the second terminal fluid connector being configured for connection to an inlet connector (23a, 92a) which is fluidically connected to a sensor (22).

Claims

1. A computer-implemented method of generating a medical fluid for renal replacement therapy, the method comprising: operating (402) a first pump (P1) to deliver a first fluid (F1) from a first container (3a) disposed on a first scale (2a) into a supply path (4a), the supply path extending to an outlet (19d) for the medical fluid; operating (403) a second pump (P2) to deliver a second fluid (F2) from a second container (3b) arranged on a second scale (2b) into the supply path (4a) to generate a mixture of the first fluid and the second fluid (F1, F2) in the supply path (4a); measuring (404) a parameter related to the composition of the mixture by means of a sensor (22); adjusting (405) the pumping speed of at least one of the first pump and the second pump (P1, P2) until the sensor (22) measures a target value for the composition-related parameter; When the sensor (22) measures the target value, determining (406) a relationship between a first weight change of the first scale (2a) and a second weight change of the second scale (2b) based on first and second output signals (S1, S2) from the first and second scales (2a, 2b); as well as The medical fluid is generated (413) in the supply path (4a), and the generation (413) includes operating the first pump and the second pump (P1, P2) based on the first output signal and the second output signal (S1, S2) to achieve the relationship between the first weight change and the second weight change.

2. The method according to claim 1, further comprising: Prior to the measurement (404), a valve arrangement (21a, 21b) is operated (401) to redirect the mixture from the supply path (4a) into a bypass path (20, 20a, 20b) which directs the mixture through the sensor (22).

3. The method according to claim 2, further comprising: When the medical fluid is generated in the supply path (4a), the valve device (21a, 21b) is operated (414) to guide the medical fluid along the supply path (4a) to the outlet (19d) of the medical fluid.

4. The method according to claim 3, wherein: The outlet (19d) is connected to a receiving device (40), and the method further includes: when the medical fluid is guided to the outlet (19d) along the supply path (4a), detecting (1101) an interruption operation of the receiving device (40); and, when the interruption operation is detected, operating (1102) the valve device (21a, 21b) to close the supply path (4a) and open the bypass path (20, 20a, 20b), and reducing (1103) the pumping speed of at least one of the first pump and the second pump (P1, P2).

5. The method according to claim 4, wherein: The reducing (1103) also includes maintaining the relationship between the first weight change and the second weight change.

6. The method according to any one of claims 2 to 5, further comprising: Prior to said operating (402) said first pump (P1) and said operating (403) said second pump (P2), a user is enabled (802) to fluidly connect said bypass path (20, 20a, 20b) to said sensor (22).

7. The method according to claim 6, further comprising: After completion of the renal replacement therapy, a procedure for ensuring the reuse of the sensor (22) is started (803).

8. The method according to claim 7, wherein: The procedure for ensuring reuse includes at least one of the following: a) operating a fluid supply device (17, 1b) including the sensor (22) to perform an operation to flush and / or sterilize the sensor (22), or b) delivering a dedicated fluid to the sensor (22) through the bypass path (20, 20a, 20b) and enabling a user to disconnect the bypass path (20, 20a, 20b) from the sensor (22) and manipulate the sensor (22) to keep the dedicated fluid in the sensor (22).

9. The method according to claim 8, wherein: The specialty fluid is bacteriostatic.

10. The method according to claim 8 or 9, wherein: The delivering of the dedicated fluid includes: operating the second pump (P2) to deliver the second fluid (F2) to the sensor (22) via the supply path (4a) and the bypass path (20, 20a, 20b), or operating the third pump (P3) to deliver the third fluid (F3) to the sensor (22) via the supply path (4a) and the bypass path (20, 20a, 20b), wherein the third fluid (F3) is included in the medical fluid together with the second fluid (F2).

11. The method according to any one of the preceding claims, further comprising: While the medical fluid is being generated in the supply path (4a), the pumping speeds of the first and second pumps (P1, P2) are monitored (416, 417) for detecting changes indicative of an operating error.

12. The method according to any one of the preceding claims, further comprising: activating (408) a third pump (P3) to deliver a third fluid (F3) from a third container (3c) arranged on a third scale (2c) into the supply path (4a), while operating the first pump (P1) to deliver the first fluid (F1) into the supply path (4a) and / or operating the second pump (P2) to deliver the second fluid (F2) into the supply path (4a) to generate another mixture in the supply path (4a); measuring (409) a parameter related to the composition of the other mixture by means of the sensor (22); adjusting (410) the pumping speed of the third pump (P3) until the sensor (22) measures another target value of the composition-related parameter; as well as when the sensor (22) measures the other target value, determining (411) another relationship between a third weight change of the third scale (2c) and at least one of the first weight change and the second weight change based on a third output signal (S3) from the third scale (2c); wherein the generating (414) includes operating the third pump (P3) based on the third output signal (S3) to achieve the other relationship between the third weight change and the at least one of the first weight change and the second weight change.

13. The method according to claim 12, wherein: During the adjustment (410), the first pump and the second pump (P1, P2) are operated simultaneously to deliver the first fluid and the second fluid (F1, F2) into the supply path (4a), and the pumping speeds of the first pump and the second pump (P1, P2) are fixed to achieve the relationship between the first weight change and the second weight change.

14. A control device comprising: Circuit (31, 32) configured to perform the method of any of the preceding claims; and, a signal interface (33a) configured to output control signals (C1, C2) for the first pump and the second pump (P1, P2) and also configured to receive the first output signal and the second output signal (S1, S2) from the first scale and the second scale (2a, 2b) and a sensor signal (S5) representing the ingredient-related parameter from the sensor (22).

15. A computer readable medium comprising computer instructions which, when executed by a processor (31), enable the processor (31) to perform the method according to any one of claims 1 to 13.

16. A system for generating a medical fluid for renal replacement therapy, the system comprising: First scale (2a); a first container (3a) arranged on the first scale (2a); Second scale (2b); a second container (3b), arranged on the second scale (3b); a supply path (4a) configured to receive a first fluid (F1) from the first container (3a) and a second fluid (F2) from the second container (3b) and extending to an outlet (19d) for the medical fluid; a first pump (P1) arranged to transfer the first fluid (F1) from the first container (3a) into the supply path (4a); a second pump (P2) arranged to convey the second fluid (F2) from the second container (3b) into the supply path (4a) to generate a mixture of the first fluid and the second fluid (F1, F2) in the supply path (4a); a sensor (22) configured to measure a component-related parameter; and A control device (30) according to claim 15.

17. The system of claim 16, wherein: The sensor (22) is reusable.

18. The system according to claim 16 or 17, further comprising: a bypass path (20, 20a, 20b) fluidly connected to the supply path (4a) and extending to the sensor (22); and a valve device (21a, 21b) operable to selectively direct the mixture from the supply path (4a) into the bypass path (20, 20a, 20b).

19. The system according to claim 18, further comprising an auxiliary sensor (122) configured to measure the ingredient-related parameter and arranged in the supply path (4a), wherein The control device (30) is configured to execute a safety procedure (1300) when a medical fluid is generated in the supply path (4a), wherein the safety procedure (1300) includes: obtaining a measurement value representing the medical fluid from the auxiliary sensor (112), evaluating the measurement value for deviation detection, and performing a specific action when a deviation is detected.

20. The system of claim 19, wherein: The auxiliary sensor (122) is a disposable component.

21. The system according to claim 19 or 20, wherein: The control device (30) is also configured to execute a calibration procedure (1310) when a medical fluid is generated in the supply path (4a), wherein the calibration procedure (1310) includes: operating the valve device (21a, 21b) to guide the medical fluid from the supply path (4a) to the bypass path (20, 20a, 20b), obtaining a first set of measurement values ​​representing the medical fluid from the sensor (22), obtaining a second set of measurement values ​​representing the medical fluid from the auxiliary sensor (122), and calculating a calibration factor based on the first set of measurement values ​​and the second set of measurement values, wherein the control device (30) is configured to adjust the measurement value by the calibration factor in the safety procedure (1300) before evaluating the measurement value.

22. A system according to any one of claims 16 to 21, wherein: A connecting line (4b) extends from the second container (3a) to a connector (6') on the supply path (4a), and the second pump (P2) is arranged in or on the second connecting line (4b) to transport the second fluid (F2) from the second container (3a) to the supply path (4a), and wherein the first pump (P1) is arranged in or on the supply path (4a) between the connector (6') and the outlet (19d) of the medical fluid.

23. A disposable device for use in the system of any one of claims 18 to 22, the disposable device comprising: A first container (3a); Supply path (4a); a connecting line (4b) in fluid communication with the supply path (4a) and extending to a first terminal fluid connector (19b) configured for connection to a second container (3b); as well as A bypass path (20, 20a, 20b) extends from the supply path (4a) to a second terminal fluid connector (19f) configured for connection to an inlet connector (23a, 92a) in fluid communication with the sensor (22).